Lantern Pharma Cash from Financing (TTM) Analysis

Lantern Pharma Inc (LTRN)

5.82 -0.21 (-3.48%) USD | NASDAQ | May 20, 16:00

5.765 -0.06 (-0.95%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	-0.4453M
December 31, 2023	-0.50M
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	0.00
December 31, 2022	-2.182M
September 30, 2022	-3.055M
June 30, 2022	-3.055M
March 31, 2022	-3.055M

Date	Value
December 31, 2021	63.42M
September 30, 2021	64.29M
June 30, 2021	64.19M
March 31, 2021	87.85M
December 31, 2020	23.66M
September 30, 2020	23.67M
June 30, 2020	24.84M
March 31, 2020	1.176M
December 31, 2019	2.920M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-3.055M

Minimum

Mar 2022

87.85M

Maximum

Mar 2021

19.10M

Average

0.5879M

Median

Cash from Financing (TTM) Benchmarks